Furthermore, GTM-1 administration reduced Aβ levels in neurons in AD mice, while the levels of APP, C99 and C83 were similar between the two groups with or without GTM-1 feeding, indicating that GTM-1 had little effect on APP processing and subsequent Aβ production. This evidence concerns the gene APP and Alzheimer disease.